Whether the gut microbiome in obesity is characterized by lower diversity and altered
composition at the phylum or genus level may be more accurately investigated using high …

The metabolome offers a dynamic, comprehensive, and precise picture of the phenotype.
Current high-throughput technologies have allowed the discovery of relevant metabolites …

Accumulating evidence indicates that the gut microbiome is an important regulator of body
weight, glucose and lipid metabolism, and inflammatory processes, and may thereby play a …

The relationship between microbiota, short chain fatty acids (SCFAs), and obesity remains
enigmatic. We employ amplicon sequencing and targeted metabolomics in a large (n …

Olive oil (OO) is the main source of added fat in the Mediterranean diet (MD). It is a mix of
bioactive compounds, including monounsaturated fatty acids, phytosterols, simple phenols …

The prevalence of overweight, obesity, type 2 diabetes, metabolic syndrome and steatotic
liver disease is rapidly increasing worldwide with a huge economic burden in terms of …

The ketogenic diet is a dietary regime focused on strongly reducing carbohydrate intake and
increasing fat intake; leading to a state of ketosis. The ketogenic diet has gained much …

To date, much progress has been made in dietary therapy for obese patients. A low-
carbohydrate diet (LCD) has reached a revival in its clinical use during the past decade with …

Obesity is a global health challenge that has received increasing attention in contemporary
research. The gut microbiota has been implicated in the development of obesity, primarily …

Obesity has a pivotal and multifaceted role in pain associated with osteoarthritis (OA),
extending beyond the mechanistic influence of BMI. It exerts its effects both directly and …